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Introduction
Sage (Salvia officinalis L.) is a popular Mediterranean aromatic herb that is 
cultivated worldwide. It is used since ancient times as a medicinal herb for treating a variety 
of ailments, such as to drying up the flow of mother`s milk, in reducing saliva secretion, as 
an anhidrotic to control night sweats associated with illness, in treating menopause problems 
and has a reputation for memory enhancement . It is also commonly used for flavouring and 
seasoning of foods, most of their properties being due to essential oils. Sage extracts have 
also been reported to have antioxidant effects and excellent properties in inhibiting lipid 
peroxidation. 
Sage derivatives continue to be important components of contemporary
phytopharmaceuticals, although their potentially toxic effects have not received much 
attention.
Methods
In this study an essential oil (EO) obtained by hydrodistillation of aerial parts of 
Salvia officinalis L. plants (12 mg/g dry weight) harvested in April 2000, cultivated in
Arouca experimental farms in northern Portugal, was characterised by GC  and GC-MS 
analyses [1]. The constituents of this essential oil are presented in table I.
The effects of the mixture on liver was investigated in freshly isolated rat 
hepatocytes in suspension, where it was used in concentrations of 0, 0.08, 0.4, 2 and 10 
μl/ml. Hepatocyte isolation was performed by collagenase perfusion as described by 
Moldéus et al. [2]. The hepatocytes were incubated in suspension with the studied 
concentrations of EO, being tert-butylhydroperoxide (t-BHP) 1mM as positive control. After 
30 min of incubation, aliquots were taken out for measurement of the following: lactate
dehydrogenase (LDH) leakage as an indicator of cell death, the thiobarbituric acid reactive 
substances (TBARS) assay as an indirect lipid peroxidation indicator, and reduced (GSH) 
and oxidised glutathione (GSSG) as indicators of the redox status of the cells by the methods 
described in [3].
Table I - Essential oil composition of S. officinalis aerial parts obtained by hydrodistillation.
Results
Figure 1 - Effect of essential oil of S. officinalis on cell death expressed 
by LDH leakage in hepatocyte suspensions after 30 min of exposure 
(means ± SEM). n=5. Significant differences were determined by one-way 
ANOVA followed by Tukey’s multiple comparison test. Differences were 
considered significant when P<0.05. * P<0.001 when compared with
control.
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Figure 2 - Effect of essential oil of S. officinalis on lipid peroxidation 
expressed by TBARS formation in hepatocyte suspension after 30 min of 
exposure (means ± SEM). n=5. For statistics see figure 1. * P<0.001 when 
compared with control.
Figure 3 - Effect of essential oil of S. officinalis on hepatocyte
suspensions GSx (total glutathione) content after 30 min of exposure 
(means ± SEM). n=5. For statistics see figure 1. 
Figure 4 - Effect of essential oil of S. officinalis on hepatocyte
suspensions GSH content after 30 min of exposure (means ± SEM). n=5. 
For statistics see figure 1. * P<0.01 when compared with control.
Figure 5 - Effect of essential oil of S. officinalis on hepatocyte
suspensions GSSG content after 30 min of exposure (means ± SEM). n=5. 
For statistics see figure 1. * P<0.05 when compared with control.
Figure 6 - Effect of essential oil of S. officinalis on hepatocyte
suspensions GSSG/GSH×100 ratio after 30 min of exposure (means ± 
SEM). n=5. For statistics see figure 1. * P<0.01 when compared with 
control.
Discussion and Conclusions
Our results show that:
- S. officinalis essential oil  (EO)  had  no toxic effects on rat hepatocyte suspensions when used in low concentrations 
(0.08 – 2 μl/ml). 
- A concentration of 10 μl/ml caused significant LDH leakage and decrease of GSH, indicative of cell damage.
- By contrast with t-BHP-induced toxicity which is the result of both GSH depletion, GSSG increase and lipid 
peroxidation, the cell death induced by the EO at 10 μl/ml was not mediated by lipid peroxidation
GSH was possibly recruited to act as a nucleophilic scavenger of some compounds and their metabolites with electrophilic
properties, via chemical mechanisms. The consequent GSH depletion may be one of the causes for the loss of viability observed 
with the high concentrations of EO, once it is known that the decrease of  this cellular antioxidant can impair the cell’s defence 
against toxic compounds and may lead to cell injury and death.
On the other hand, the cellular death indicated by LDH leakage can be due to a solvent effect of the essential oil, because it 
is composed mainly by hydrophobic compounds (table I). These compounds may exert a direct action on cellular membranes by 
disturbing the physico-chemical properties of the bilayer which could culminate with the disruption of cellular volume and cell 
death.
Concluding, our results show that care should be taken when using essential oils of sage in the food industry or as 
alternative medicines because of their potentially toxic effects on the liver. However, more studies should be carried out to 
elucidate the mechanisms of toxicity of this essential oil and determine the active compound(s) in the mixture.
References
[1] Santos-Gomes P.C., Fernandes-Ferreira M. (2001), Organ- and season-dependent variation in the essential oil composition of Salvia 
officinalis L. cultivated at two different sites. J. Agric. Food Chem. 49: 2908-16
[2] Moldéus P., Högberg J., Orrenius S. (1978), Isolation and use of liver cells. Methods in Enzymology, 52: 60-71
[3] Fernandes, E.R., Carvalho, F.D., Remião, G., Bastos, M.L., Pinto, M.M., Gottlieb, O.R. (1995), Hepatoprotective
activity of xanthones and xanthonolignoids against tert-butylhydroperoxide-induced toxicity in isolated rat hepatocytes
– comparison with silybin. Pharmaceut. Res. 12: 1756-60
0
5
10
15
20
25
30
35
40
45
50
0(contr) 0,08 0,4 2 10 t-BHP
EO concentration (μ l/ml)
G
Sx
 (n
m
ol
/m
ill
io
n 
ce
lls
)
0
5
10
15
20
25
30
35
40
0(contr) 0,08 0,4 2 10 t-BHP
EO concentration (μ l/ml)
G
SH
 (n
m
ol
/m
ill
io
n 
ce
lls
)
*
0
2
4
6
8
10
12
14
0(contr) 0,08 0,4 2 10 t-BHP
EO concentration (μ l/ml)
G
SS
G
 (n
m
ol
/m
ill
io
n 
ce
lls
)
*
0
20
40
60
80
100
120
0(contr) 0,08 0,4 2 10 t-BHP
EO concentration (μ l/ml)
G
SS
G
/G
SH
 x
 1
00
*
Peak nº Compound name % μg/g dry wt
1 1-Butyl acetate 0,03 3,6
2 cis-2-Methyl-3-methylene-hep-5-ene 1,01 98,8
3 trans-2-Methyl-3-methylene-hep-5-ene 0,11 11,6
4 Tricyclene 0,03 2,0
5 α-Thujene 0,24 23,1
6 α-Pinene 1,00 97,9
7 Camphene 0,62 59,3
8 Sabinene 0,48 47,4
9 β -Pinene 4,02 395,8
10 Myrcene 0,67 66,2
11 n-Decane tr 1,4
12 α-Phellandrene 0,03 3,0
13 α-Terpinene 0,16 15,0
14 P-Cymene 0,08 7,1
15 Limonene 0,44 43,6
16 1,8-Cineole 7,98 1070,9
17 cis-β -Ocimene 2,84 278,8
18 trans-β-Ocimene 0,62 60,8
19 γ-Terpinene 0,35 33,8
20 trans-Sabinene hydrate and/or cis-Linalool oxide 0,22 28,4
21 Not identified 0,03 2,4
22 Terpinolene 0,13 12,9
23 n-Undecane 0,13 17,2
24 Linalool
25 α -Thujone 32,10 4311,3
26 β -Thujone 2,96 396,3
27 α-Campholenal 0,03 2,9
28 Not identified 0,20 26,9
29 Camphor 2,18 291,5
30 Not identified 0,02 2,0
31 (cis-3-)-Pinanone 0,08 10,7
32 Borneol 2,10 282,6
33 Pinocamphone isomer (T) 0,03 3,5
34 4-Terpineol 0,19 26,3
35 α-Terpineol 0,17 23,6
36 Not identified 0,03 4,7
37 Not identified tr 1,5
38 Not identified 0,04 5,4
39 Bornyl acetate and/or Isobornyl acetate 0,24 32,7
40 cis-Sabinyl acetate 0,06 7,3
41 Not identified 0,03 3,0
42 δ-Terpineol (T) (?) tr 1,2
43 δ-Elemene 0,08 6,7
44 trans-Carvyl acetate
45 Not identified
46 cis-Carvyl acetate tr 1,2
47 Neryl acetate 0,08 10,5
48 β-Bourbonene + Geranyl acetate 0,06 7,6
49 β -Caryophyllene 7,70 759,9
50 Aromadendrene or α-Guaiene (?) 0,09 9,2
51 α -Humulene 9,03 889,0
52 allo-Aromadendrene 0,09 8,9
53 Germacrene D isomer #3 0,21 20,3
54 Germacrene D 0,26 25,6
55 α-Selinene 0,16 15,8
56 δ-Cadinene 0,26 26,3
57 Caryophyllene oxide and/or Globulol 0,35 45,2
58 Viridiflorol 10,94 1462,4
59 Widdrol (?) 0,53 70,9
60 trans-α-Bergamatol acetate or (E), cis, epi-β-Santalol acetate (?) 0,07 11,3
61 Not identified 0,05 5,6
62 Manool 8,05 806,1
63 Not identified 0,32 39,2
64 Not identified 0,03 3,3
Grouped components % μg/g dry wt
Monoterpene hydrocarbons 12,86 1259,4
Oxygen-containing monoterpenes 48,31 6489,8
Monoterpenyl esters 0,40 54,6
Sesquiterpene hydrocarbons 17,88 1761,7
Oxygen-containing sesquiterpenes 11,82 1578,5
Sesquiterpenyl esters 0,07 11,3
Oxygen-containing diterpenes 8,05 806,1
n-Alkanes 0,13 18,6
Others 0,48 59,3
total 100 12039,3
tr - trace amounts
